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A large group one-session exposure treatment (LG-OST) based on indirect modeled
exposure strategies was carried out to investigate its feasibility and effectiveness in
a sample of highly spider fearful individuals (N = 78). The stability of LG-OST-effects
was assessed at 8-month follow-up (FU). Furthermore, a second sample (N = 30) of
highly spider fearful individuals was treated in a standard, single-person one-session
treatment (SP-OST) design to compare LG-OST-effects to a standard spider fear
treatment. Participants’ fear of spider was assessed by multiple questionnaires and
by a behavioral approach test. The fear assessment took place before and after the
respective intervention, and at 8-month FU in LG-OST. Regarding subjective spider
fear measures, LG-OST mainly showed medium to large effect sizes, ranging from
Cohen’s d = 0.69 to d = 1.21, except for one small effect of d = 0.25. After LG-OST,
participants approached the spider closer at post-treatment measures (d = 1.18). LG-
OST-effects remained stable during the 8-month FU-interval. However, SP-OST-effects
proved superior in most measures. An LG-OST-protocol provided evidence for feasibility
and efficiency. The effects of LG-OST were equal to those of indirect modeled exposure
strategies, carried out in single-settings. LG-OST may represent a useful tool in future
phobia-treatment, especially if it can match the effects of single-setting OST, e.g., by
including more direct exposure elements in future large group attempts.
Keywords: exposure therapy, group treatment, participant modeling, one-session treatment, spider fear
treatment, spider fear
INTRODUCTION
In Europe, patients’ demand on cognitive behavioral psychotherapy is likely to increase in the
future (Ginger, 2009). However, the existing health care system has not kept up with the growing
demand and cannot sufficiently cover the urgent need for treatment. In some rural areas of
Germany, for instance, a psychotherapist is expected to cover the needs of 23.000 inhabitants
(Walendzik et al., 2010). Patients are forced to accept long waiting periods and might face avoidable
‘chronifications’ of disorders. Therefore, more efficient treatment approaches to improve clinical
effectiveness should be developed.
With a 12-month prevalence rate between seven and nine percent in western countries
(American Psychiatric Association, 2013) Specific Phobias are the most common amongst anxiety
disorders. Although widely considered as less restrictive, the disability level resulting from different
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phobic disorders is highly variable ranging from relatively
minor (i.e., spider phobia; snake phobia) to more debilitating
(i.e., emetophobia; dental phobia). A survey conducted by the
German Federal Ministry of Health (Wittchen and Jacobi, 2004)
showed the high health-economic relevance of specific phobias
by reporting a mean of 4.2 days of absence from work per month
for men and 2.6 for women suffering from a Specific Phobia. The
population mean of monthly absence was reported to be 0.9 days.
Short and intense exposure-based treatments are already a part
of the treatment of many anxiety disorders, especially phobic
disorders. In some cases such treatments consist of a single
session lasting for 3 h or even less. Originally such one-session
treatments (OSTs), first introduced by Öst (1989), consisted of
exposure in vivo and elements of participant modeling. However,
cognitive and motivational aspects have been added through
psychoeducative elements, skills training, reinforcement, and
cognitive challenges (Zlomke and Davis, 2008). During a typical
OST, the therapist encourages the patient to interact with the
feared stimulus by mastering a step of a subjective fear hierarchy.
The therapist challenges patient’s beliefs in the context of the
fear-evoking stimulus and motivates him to emulate. Later on,
therapist’s support is restricted to instructions and presence only.
One-session treatments have successfully been applied to a
wide range of specific phobias, i.e., animal phobias including
spider phobia (Öst et al., 1991; Hellström and Öst, 1995), flight
phobia (Öst et al., 1997a), dental phobia (Haukebø et al., 2008),
injection phobia (Öst et al., 1992) and agoraphobia (Öst et al.,
2001). Across phobic disorders, OSTs show clinical improvement
rates of 80–90% (Zlomke and Davis, 2008), proving a very high
efficacy in the treatment of adults.
In spite of the short and effective treatment format, the
efficiency of OSTs is restricted by the typical single-setting design.
Therefore, it would be beneficial to reduce the therapist-patient
ratio, i.e., via group treatment, to maximize treatment-efficiency.
Indeed, there are three studies, in which one session
treatments were delivered in a group setting. They all were
conducted in small groups of spider fearful individuals. Two
of these studies (Öst et al., 1997b; Götestam, 2002) focused on
concepts about the delivery of exposure and modeling elements,
the other (Öst, 1996) addressed the question whether group size
influences therapy outcome. Götestam (2002) investigated three
kinds of OSTs in groups of spider phobic individuals where
exposure was either delivered directly, indirectly or via a film
clip. He reported modeled exposure, where only one participant
and the therapist work together in front of the group or filmed
modeling being both effective fear reducing strategies. However,
direct exposure where each participant worked with his/her own
spider proved slightly superior. However, Öst et al. (1997b) found
a significant difference between the treatment effects of direct
and indirect OST-group approaches with direct exposure yielding
larger and more stable outcomes over time. Moreover, Öst (1996)
showed that the effects of smaller groups (n = 3–4) in most
measures did not differ significantly from those of larger groups
(n = 7–8). However, there was a trend for the small group
condition to result in better effects. In sum, small group OSTs
proved feasible and effective, especially when employing direct
exposure elements.
Furthermore, there was a non-clinical aspect encouraging
us to invent an exposure based large-group treatment-protocol.
Exposure treatments are often considered as an analog to
extinction in laboratory fear studies (Hermans et al., 2006)
and the construction of clinical exposure treatments has greatly
benefitted from the results of experimental basic research on
fear (Craske and Mystkowski, 2006). However, clinical trials are
intensive with respect to recruitment-, cost-, and time-related
issues; a reason for the gap between basic and applied clinical
research. Therefore, feasible large-group treatment formats could
enable direct and efficient transfer of mechanistic findings into
clinical treatment research designs. Consequently, it would be
easier to investigate the external validity of mechanisms identified
under laboratory conditions.
Based on these insights, we developed an OST-protocol for a
large group setting (LG-OST) that should contain well-evaluated
OST-exposure strategies for specific phobias suitable for more
than 50 participants. Following the concept of evidence-based
psychotherapy (Norcross et al., 2006), in this Phase I open trial
we primarily focused on feasibility aspects of LG-OST in a
non-clinical sample of highly spider fearful individuals. Hence,
this study does not contain a direct control group condition.
However, with future research on LG-OST in mind, we compared
the effects of a non-randomized LG-OST condition to a non-
randomized single person OST (SP-OST). According to the
recommendations of Öst (1989), SP-OST combines modeled
and direct exposure elements and is routinely conducted in the
same treatment center and accessible for the same cohort as
LG-OST. We did not expect LG-OST to equal the recent ‘OST-
gold standard.’ However, we aimed at bringing forth a first
classification of LG-OST-results by comparing it to a one-session-
single-person treatment condition (SP-OST). Furthermore we
wanted to explore whether there are predictors for LG-OST
success.
To the best of our knowledge, the delivery of a psychological
treatment simultaneously to 50 or more individuals has never
been conducted to date. Consequently, we were cautious of
participants’ fear responses in a direct exposure setting with
many spiders and their possible difficulties in dealing with them.
Therefore, for the better control of fear responses, we included
both live and filmed modeling modules in our LG-OST-protocol,
although filmed modeling has been proven slightly less effective
than direct exposure strategies.
MATERIALS AND METHODS
Participants
For this Phase I study, initially 100 individuals registered for LG-
OST online on a website established for this project. They were
recruited by advertisements on local radio, newspapers and social
networks. There were only two requirements to participate in the
project: high subjective spider fear or avoidance and being full of
age (18 years). Finally on the day of the group treatment, N = 78
participants, all Caucasian (67 female, 9 male) with a mean age of
34.65 (SD = 13.39) years showed up at the treatment-day where
they gave their informed consent to attend LG-OST.
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After the LG-OST, online-recruitment took place for SP-OST.
Preconditions for participation in the SP-OST were the same
as for LG-OST. Initially 35 individuals declared interest in SP-
OST-participation. However, an appointment could be arranged
only with 30 participants (27 female, 3 male) who were also all
Caucasian, with a mean age of 27.40 (SD= 6.80) years.
Exclusion criteria for both LG-OST and SP-OST were allergic
reactions to spider or insect bites or stings. Prior participants of
the LG-OST were excluded from the SP-OST. The local Ethics
Committee of the psychology faculty of the Ruhr-University
Bochum, where the study was conducted, approved the study.
Informed consent procedure was carried out with participants.
Procedure
Prospects were informed on our website that they would remain
anonymous during the treatment. Prior to the intervention,
participants were given an ID-number for data collection
and assembling. Four postgraduate clinical psychologists, who
were all well trained in spider phobia treatment, performed
the LG-OST and SP-OST. Both conditions were preceded
and followed instantaneously by a behavioral approach test
(BAT). During the BAT, participants had to approach a living
spider. Moreover, participants completed a set of questionnaires,
assessing subjective and cognitive components of spider fear
pre- and post-intervention. Before leaving, all participants were
asked to voluntarily sign up and to be available for FU-measures.
Twenty-nine participants (37.2%) registered (see Figure 1). After
8 months, we invited them for FU-measurement consisting of the
same BAT and questionnaires.
Treatment
LG-OST (Duration 120 Min)
Large group one-session exposure treatment was delivered to
the patients in an auditorium of the Ruhr-University Bochum,
consisting of three phases.
Psychoeducation phase (about 30 min)
After entering the auditorium, participants received information
about spiders via a 20-min movie-clip. In this clip, a biologist
specialized in research on spiders, targeted often-feared myths
about spiders’ behavior, i.e., their potential aggressiveness,
deceitfulness or toxicity.
Afterward, the psychotherapist explained the nature and
utility of fear and its cognitive, behavioral and subjective
consequences. He outlined the aim of the following treatment as a
strategy to habituate to fear reactions and to reduce fear of spider’s
behavior by learning to predict and control it. Participants were
instructed that fear responses during the session would be normal
and even useful because they could accelerate habituation effects.
Filmed modeling phase (about 50 min)
Exposure was delivered via video presentation introducing four
spiders in sequence: a cellar spider (Pholcus phalangioides), a
garden spider (Araneus diadematus), a long-legged male and a
short-legged female barn funnel weaver (Tegenaria atrica). The
instructor asked participants to mentally describe all physical
aspects of the spiders as precisely as possible as if they were
to describe them to a blind person, thereby avoiding the use
of negative predicates in their descriptions. Afterward, a direct
modeled exposure, based on the recommendations of Öst (1989)
was presented in the clip.
Live modeling phase (about 40 min)
After the video presentation, the psychotherapist asked one
volunteer from the auditorium to repeat the program depicted
in the video with a living barn funnel weaver. Other participants
observed the process.
SP-OST (Duration 120 Min)
We presented the same movie clip with information about
spiders as in the LG-OST-condition and participants received
the same psycho-educative information as in LG-OST. All
participants were treated based on the one-session-treatment
concept of Öst (1989), which combines gradual exposure
and modeling. According to their subjective fear reduction,
participants indicated their willingness to proceed to the next
step. The program was finished after the participant had reached
the last step or after a total duration of 2 h.
Measures
Behavioral Approach Test
A BAT was performed using a test with a living spider (Tegenaria
domestica). At pre-, post-, and FU-measuring points, participants
were instructed to undergo five steps: (1) To go through a 5 m
long corridor and approach a desk with a well visible living barn
funnel weaver captured in a drinking glass; (2) To touch the glass
with the spider; (3) To place their other hand on the glass; (4) To
lift the glass to their face; (5) To turn the glass upside down and
touch the spider. It was scored whether a participant managed to
cope with a respective step for at least 5 s.
Subjective Spider Fear Measures
The German version of the Spider Phobia Questionnaire (SPQ,
Rinck et al., 2002) consists of 43 dichotomous items (yes/no),
covering three dimensions of spider fear: vigilance (6 items),
preoccupation (17 items) and avoidance-coping (10 items).
Furthermore, the SPQ contains five items dealing with facts about
spiders and five cognitive-behavioral items not being assigned to
any scale. The authors reported a total mean score of M = 16.7
(±6.2) in highly spider fearful individuals. In our sample, internal
consistency of the SPQ was good (Cronbachs’ α = 0.85) with
the subscales ranging from α = 0.62 (vigilance) to α = 0.79
(preoccupation).
The German version of the Fear of Spider Questionnaire (FSQ,
Rinck et al., 2002) consists of 18 items with 7-point Likert-
scales (0 = not at all true; 6 = exactly true). The mean score
of highly spider fearful persons was reported to be 58.7 (±22.2).
Internal consistency (Cronbachs’ α = 0.96) and retest reliability
(rtt = 0.95) were reported as excellent. In our sample, internal
consistency was Cronbachs’ α= 0.93.
The German Spider Fear Screening (Rinck et al., 2002)
is a short self-rating instrument consisting of four items all
conceiving the relevant DSM-IV criteria for spider phobia on a
7-point Likert-scale. The authors report mean scores of 1.6 (±1.2)
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FIGURE 1 | Flow diagram of patients entering the study.
for non-fearful individuals and 21.4 (±2.3) for individuals with
a diagnosed spider phobia. It has a good internal consistency,
Cronbach’s α = 0.92, and a retest reliability of rtt = 0.88. We
found a good reliability of Cronbach’s α = 0.82 of this four-item
measure in our sample.
Dysfunctional Spider-Related Cognitions
The German version of the Spider Belief Questionnaire (Pössel
and Hautzinger, 2003) consists of 48 items, measuring
dysfunctional beliefs. The questionnaire consists of two
groups of items measuring beliefs regarding (a) spider-
related endangerment (five subscales: ‘Hunter and Victim’ i.e.,
spiders pursue the individual; ‘Unpredictability’; ‘Aggression’;
‘Multiplication’ [i.e., spider will grow and new spiders will show
up]; ‘Territory’ [i.e., spiders will intrude the private sphere]) and
(b) self-related reactions and coping (three subscales: Panic and
uncontrollable reactions, Paralysis, Nightmares). Participants
indicate the degree to which the respective statement applies
to them (0–100). The authors of the German SBQ report
an excellent internal reliability of Cronbach’s α = 0.98 with
the subscales ranging from 0.82 to 0.96. Here, we found an
internal consistency of Cronbach’s α = 0.95 for the total
scale.
Clinical State
A German 21-item version of the Depression Anxiety Stress
Scale (Lovibond and Lovibond, 1995) was used. This self-rating
questionnaire measuring negative emotional status is answered
on a 7-item Likert-scale. Besides the mean score, a set of seven
items constitutes three separate scales: depression, anxiety and
stress. Here, we found an internal consistency of Cronbach’s
α = 0.90 for the total scale, with subscales ranging from
Cronbach’s α= 0.90 (depression) to 0.78 (stress).
The German version of the State-Trait Anxiety Inventory
(STAI, Laux et al., 1981) consists of two subscales, each describing
emotional state in 20 statements at present (state) and during the
last 2 weeks (trait version). Scores range from 20 (no anxiety) to
80 (high anxiety). Whereas the state-scale is highly sensitive for
change, the trait-scale has a high retest reliability (rtt < 0.96).
Global-Success-Rating (GSR)
On a 7-item Likert-scale, participants rate subjective state
changes from 1 (much worse) to 7 (much better). A score of 4
indicates no subjective change.
Statistical Analysis
Due to absence of premature attrition, analysis on change
was carried out as completer analyses using repeated measures
ANOVA. Between measures, n could slightly differ, i.e., due to
falsely completed questionnaires. We calculated within-group
effect sizes using Cohen’s d formula based on pooled standard
deviations (Cohen, 1988). Moreover, partial eta-square values
(η2) as measures for effect-size were given, for within- and
between-group comparisons. In case of significant pre-treatment
differences between LG-OST- and SP-OST- participants, repeated
measures ANCOVA were used for between-group comparisons.
Only 37% of the participants returned for FU-assessment in
the LG-OST-condition. To test weather drop-out was selective;
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TABLE 1 | Means, SDs and effect strengths (Cohen’s d) of pre- to post changes of spider fear measures for LG-OST-condition.
LG-OST (n = 78)
Pre Post Pre > Post
M (SD) M (SD) Statistics ES# [95 % CI]
Sample characteristics and clinical data
Age (years) 34.65 (13.39) – – –
STAI-S 42.01 (5.08) 40.90 (5.52) F (1,70) = 3.38∗, η2 = 0.05 0.21 [0.54 – (−0.12)]
STAI-T 41.52 (11.12) – – –
DASS 16.36 (10.11) – – –
Spider fear measures
SBQ (total) 50.56 (21.00) 27.07 (17.24) F (1,70) = 208,11∗∗∗, η2 = 0.75 1.21 [1.55 −0.83]
SBQ subscales
Panic 66.81 (27.60) 37.07 (26.88) F (1,70) = 153,15∗∗∗, η2 = 0.69 1.09 [1.44 −0.74]
Paralyze 34.52 (35.21) 20.68 (29.50) F (1,70) = 24.55∗∗∗, η2 = 0.26 0.43 [0.76 −0.09]
Nightmare 57.87 (30.17) 31.03 (28.17) F (1,70) = 85.00∗∗∗, η2 = 0.55 0.92 [1.27 −0.57]
Unpredict. 73.41 (21.07) 47.82 (22.20) F (1,70) = 138,05∗∗∗, η2 = 0.66 1.18 [1.54 −0.83]
Territory 46.28 (25.25) 22.79 (20.79) F (1,70) = 85.68∗∗∗, η2 = 0.55 1.02 [1.37 −0.67]
Victim. 28.65 (24.35) 7.69 (11.79) F (1,70) = 82.06∗∗∗, η2 = 0.54 1.01 [1.45 −0.74
Multipl. 23.41 (28.22) 11.17 (16.29) F (1,70) = 25.78∗∗∗, η2 = 0.27 0.53 [0.87 −0.20]
Aggress. 22.90 (28.92) 6.54 (11.65) F (1,70) = 38.60∗∗∗, η2 = 0.36 0.74 [1.08 −0.40]
SFS (total) 19.51 (5.22) 15.43 (6.42) F (1,73) = 77.86∗∗∗, η2 = 0.52 0.69 [1.01 −0.36]
FSQ (total) 61.83 (25.24) 40.01 (23.41) F (1,70) = 96,35∗∗∗, η2 = 0.58 0.88 [1.22 −0.53]
SPQ (total) 17.73 (6.11) 16.00 (7.30) F (1,72) = 14.85∗∗∗, η2 = 0.17 0.25 [0.57 – (−0.08)]
SPQ subscales
Vigilance 4.26 (4.14) 4.13 (1.49) F (1,72) = 1.11, η2 = 0.02 –
Preoccupation 6.60 (3.61) 6.13 (4.28) F (1,71) = 3.56, η2 = 0.05 –
Avoid.Cop 6.88 (2.39) 5.90 (2.72) F (1,71) = 24.41∗∗∗, η2 = 0.26 0.38 [0.71 −0.01]
BAT steps 1.04 (1.41) 2.68 (1.37) F (1,71) = 105.12∗∗∗, η2 = 0.60 −1.18 [(−1.53) – (−0.83)]
GSR – 5.13 (0.94) – –
STAI, State-Trait Anxiety Inventory; DASS-21, Depression Anxiety Stress Scale; SBQ, Spider Belief Questionnaire; Unpred., Unpredictability; Multipl., Multiplication;
Aggress., Aggression; SFS, Spider Fear Screening; FSQ, Fear of Spider Questionnaire; SPQ, Spider Phobia Questionnaire; GSR, Global Success Rating; Preoccupat.,
Preoccupation; Avoid.Cop, Avoidance-Coping; BAT, Behavioral Approach Test; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; #Effect sizes not reported when pre- to post
changes were not significant.
we initially compared FU-completers and non-completers with
univariate ANOVA for every pre-treatment and all outcome
measures. Afterward, the stability of LG-OST-effects was
analyzed with repeated measures ANOVA within FU-completers.
To reduce LG-OST outcome measures, we initially conducted
a factor analysis choosing a non-rotated factor solution,
including all pre-post change scores. Afterward, Pearson
correlation-analyses were conducted to identify variables that
were significantly associated with LG-OST-treatment outcome.
Afterward, these variables were included in the multiple
regression analysis. All analyses were conducted using the IBM
SPSS Statistics program.
RESULTS
Is LG-OST Effective in Reducing Spider
Fear?
Regarding total scores, ANOVA showed highly significant
decreases from pre- to post-treatment in all subjective spider
fear measures and the BAT. With the exception of two subscales
of the SPQ (Vigilance and Preoccupation), all subscale-changes
were highly significant as well. For the total scores, the effect sizes
(Cohen’s d) ranged from large effects d = 1.21 (SBQ) to small
effects of Cohen’s d = 0.25 (SPQ), as depicted in Table 1.
What Are Predictors for
LG-OST-Outcome?
To reduce the dimensions of therapy outcome, we initially
conducted a factor-analysis with non-rotated factors including all
pre to post differences concerning subjective spider fear- (SFS,
SBQ, SPQ, FSQ), behavioral spider fear- (BAT) and state-fear
(STAI-State) measures. A two factor- solution (Eigenwerte > 1)
explained 66.09% of the total variance. All spider fear measures
loaded high (all loads > 0.67) on the first factor ‘spider fear
decrease’ which explained 48.40% of the total variance. The
STAI-State loaded high (0.92) on the second factor ‘state-fear
decrease,’ explaining 17.69% of the total variance. No spider
fear measure loaded higher than 0.30 (BAT) on the second
factor.
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TABLE 2 | Means, SDs, CI’s and effect strengths (Cohen’s d) of post- to FU changes of spider-fear measures for LG-OST-participants completing
FU-measures.
LG-OST (n = 29)
Pre Post FU
M (SD) M (SD) M (SD) Statistics ES# [95% CI]
SBQ total 50.63 (18.57) 28.90 (18.07) 31.54 (19.97) F (1,27) = 0.67, n.s. –
SBQ subscales
Panic 68.70 (25.70) 41.19 (29.73) 44.14 (32.72) F (1,27) = 0.57, n.s. –
Paralyze 37.52 (35.95) 24.92 (33.96) 18.29 (25.24) F (1,27) = 2.18, n.s. –
Nightmare 61.79 (27.70) 39.70 (31.47) 43.87 (34.58) F (1,27) = 0.53, n.s. —
Unpred. 77.21 (14.39) 49.66 (20.71) 56.37 (24.70) F (1,27) = 2.07, n.s. –
Territory 44.62 (24.93) 23.63 (21.74) 29.22 (25.35) F (1,27) = 1.24, n.s. –
Victim. 25.32 (25.75) 6.43 (8.82) 8.13 (9.20) F (1,27) = 0.83, n.s. –
Multipl. 21.54 (29.93) 7.99 (15.62) 7.90 (13.32) F (1,27) = 0.97, n.s. –
Aggress. 14.02 (21.49) 3.84 (8.84) 3.79 (7.80) F (1,27) = 0.00, n.s. –
SFS 20.86 (3.57) 16.66 (5.68) 15.24 (6.47) F (1,28) = 1.65, n.s. –
FSQ 62.82 (24.71) 42.89 (24.79) 38.25 (27.25) F (1,27) = 1.04 –
SPQ total 18.35 (6.22) 17.00 (7.08) 13.97 (6.26) F (1,28) = 11.78∗∗, η2 = 0.30 0.45 [0.98 −0.07]
SPQ subscales
Vigilance 4.28 (1.41) 4.21 (1.42) 4.03 (1.72) F (1,28) = 0.75, n.s. –
Preoccupat. 7.21 (3.75) 6.79 (4.02) 5.07 (3.47) F (1,28) = 9.29∗∗, η2 = 0.25 0.46 [0.98 −0.06]
Avoid.Cop. 6.86 (2.45) 6.00 (2.96) 4.86 (2.37) F (1,28) = 6.43∗, η2 = 0.19 0.43 [0.95 −0.10]
BAT steps 1.15 (1.49) 2.73 (1.37) 2.58 (0.61) F (1,25) = 0.49 –
GSR – 5.02 (1.13) 5.36 (0.88) F (1,25) = 1.44 –
SBQ, Spider Belief Questionnaire; Unpred., Unpredictability; Multipl., Multiplication; Aggress., Aggression; SFS, Spider Fear Screening; FSQ, Fear of Spider Questionnaire;
SPQ, Spider Phobia Questionnaire; Preoccupat., Preoccupation; Avoid.Coping, Avoidance-Coping; BAT, Behavioral Approach Test; GSR, Global Success Rating,
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; #Effect sizes not reported when post- to FU-changes were not significant.
Subsequently, we conducted correlation analyses between
‘spider fear decrease’ factor-scores and age, clinical baseline-
status (DASS, STAI-Trait) and all spider fear pre scores
in the LG-OST condition. A significant result was shown
for age (r = −0.28, p < 0.05) with younger participants
benefitting more than older ones. More dysfunctional spider-
related cognitions at baseline in the SBQ (r = 0.27, p < 0.05)
and higher subjective spider fear levels in FSQ (r = 0.37,
p < 0.05) were both positively associated with treatment
outcome. However, there were no significant correlations
between ‘spider fear decrease’ and clinical status (DASS,
STAI-T).
A multiple regression analysis with stepwise inclusion of FSQ,
age and SBQ yielded best variance explanation (R2 = 0.21) for
a model combining FSQ (β = 0.36, t = 3.23, p < 0.01) and age
(β=−0.26, t =−2.34, p< 0.05).
Are the Effects of LG-OST Stable Over
Time?
Twenty-nine LG-OST-participants (85.7% female, 14.3% male)
returned for FU-measures. Mean time between post- and
FU-measure was 8.96 months (SD = 1.79). To investigate
selective drop-out effects, we compared gender with χ2-test and
all baseline measures for FU-completers and non-completers
(n = 49) with univariate ANOVA. With the exception of
one subscale (Aggression) of the SBQ, where FU-completers
reported significantly more dysfunctional beliefs [F(1,75)= 4.33,
p = 0.041], there were no significant differences between groups
at baseline-assessment neither in regard to sociodemographics
and clinical state, nor spider-fear measures. The same non-
significant results were found for all pre- to post-change
scores. FU-completers and non-completers did not differ in
any of them (all p > 0.05). Hence, we assume that the
post-treatment to FU drop-out was random within the LG-
OST-condition. As depicted in Table 2, with the exception
of SPQ, FU-completer analyses showed no significant changes
from post-treatment to FU, indicating time-stable effects of
LG-OST.
The pre to post change-effects within the SPQ were small (see
Table 1). However, SPQ was the only measure where LG-OST-
participants showed a significant decrease from post-treatment
to FU.
Are the Post-treatment Effects of
LG-OST within a Non-randomized
Sample Equal to those of a
Non-randomized One-Session Single
Training (SP-OST)?
To offer a clearer classification of LG-OST-outcomes, we
compared LG-OST effects with those of SP-OST, where 30
individuals were treated in a one session-session single treatment.
For SP-OST sample characteristics, clinical state and spider fear
see Table 3.
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TABLE 3 | Means, SDs and effect strengths of pre- to post changes (Cohen’s d) of spider fear measures for SP-OST.
SP-OST (n = 30)
Pre Post Pre > Post
M (SD) M (SD) Statistics ES# [95% CI]
Sample characteristics and clinical data
Age (years) 27.39 (6.80) – – –
STAI-S 41.87 (4.13) 40.97 (4.66) F (1,29) = 0.33, n.s. –
STAI-T 39.50 (8.24) – –
DASS 11.80 (6.92) – – –
SBQ (total) 49.41 (18.95) 23.24 (14.79) F (1,29) = 78.89∗∗∗, η2 = 0.73 1.54 [2.11 −0.96]
SBQ subscales:
Panic 66.98 (29.23) 31.13 (27.48) F (1,29) = 56.76∗∗∗, η2 = 0.66 1.26 [1.82 −0.71]
Paralyze 31.82 (32.49) 15.89 (21.66) F (1,29) = 14.39∗∗∗, η2 = 0.33 0.58 [1.09 −0.06]
Nightmare 59.60 (30.27) 30.00 (27.48) F (1,29) = 41.67∗∗∗, η2 = 0.59 1.02 [1.56 −0.49]
Unpred. 67.32 (19.88) 39.28 (17.03) F (1,29) = 83.53∗∗∗,η2 = 0.74 1.52 [2.09 −0.94]
Territory 52.21 (28.68) 19.52 (18.18) F (1,29) = 43.89∗∗∗, η2 = 0.60 1.34 [1.90 −0.78]
Victim. 22.84 (23.00) 3.04 (6.19) F (1,29) = 24.69∗∗∗, η2 = 0.46 1.18 [1.72 −0.06]
Multipl. 20.78 (23.15) 5.94 (10.75) F (1,29) = 22.36∗∗∗, η2 = 0.44 0.82 [1.35 −0.30]
Aggress. 21.97 (23.23) 4.23 (8.20) F (1,29) = 23.27∗∗∗,η2 = 0.45 1.02 [1.56 −0.48]
SFS (total) 20.11 (4.08) 12.04 (5.59) F (1,29) = 83.93∗∗∗, η2 = 0.74 1.65 [2.24 −1.06]
FSQ (total) 66.71 (23.85) 34.68 (19.34) F (1,29) = 95.50∗∗∗, η2 = 0.77 1.48 [2.05 −0.90]
SPQ (total) 18.77 (6.36) 16.20 (6.86) F (1,29) = 9.34∗∗, η2 = 0.24 0.38 [0.89 −0.13]
SPQ subscales:
Vigilance 4.00 (1.60) 4.20 (1.37) F (1,29) = 1.53, η2 = 0.05 –
Preoccup. 7.47 (3.94) 6.40 (4.68) F (1,29) = 5.69∗, η2 = 0.16 0.25 [0.76 – (−0.26)]
Avoid.Coping 7.30 (2.22) 5.60 (3.73) F (1,29) = 7.43∗, η2 = 0.20 0.55 [1.07 −0.04]
BAT steps 0.23 (0.61) 3.32 (0.76) F (1,29) = 447.10∗∗∗, η2 = 0.94 −4.48 [(−3.54) – (−5.43)]
GSR – 5.97 (0.78) – –
STAI, State-Trait Anxiety Inventory; DASS, Depression Anxiety Stress Scale; SBQ, Spider Belief Questionnaire; Unpred., Unpredictability; Multipl., Multiplication; Aggress.,
Aggression; SFS, Spider Fear Screening; FSQ, Fear of Spider Questionnaire; SPQ, Spider Phobia Questionnaire; Preoccupat., Preoccupation; Avoid.Cop, Avoidance-
Coping; BAT, Behavioral Approach Test; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; GSR, Global Success Rating; #Effect sizes not reported when pre- to post-changes were
not significant.
Gender-distributions did not differ between the LG-OST- and
SP-OST-conditions (χ2 = 0.07, p = n.s.). However, participants
of the LG-OST-condition were significantly older than SP-OST-
participants [F(1,105) = 7.49, p < 0.01] and expressed higher
mental distress in the German DASS-21 [F(1,105) = 5.12,
p< 0.05].
To this end, we used ANCOVA partialing-out the age and
DASS-differences for all spider fear comparisons between groups.
Initially, we analyzed whether there were baseline differences
between groups in regard to spider fear. However, for none of the
subjective measures differences were found (all age- and mental
distress-adjusted means p > 0.05). BAT at pre-treatment showed
that participants of the LG-OST-group approached the spider
closer than SP-OST-participants [F(1,99) = 10.27, p < 0.01,
η2 = 0.09).
Regarding differential pre- to post changes (group × time
interactions), outcomes differed between groups in the FSQ
[F(1,94)= 6.70, p< 0.05, η2 = 0.07] and in SFS [F(1,97)= 16.70,
p < 0.001, η2 = 0.15], with SP-OST resulting in larger effects
than LG-OST in both measures. In the SPQ [F(1,95) = 0.91,
p = n.s.] and in SBQ [F(1,96) = 0.42, p = n.s], however,
changes did not significantly differ between groups. The
two groups differed highly significantly in approaching the
spider after treatment [F(1,94) = 15.98, p < 0.001], with a
better performance in SP-OST than LG-OST-participants (see
Figure 2).
In regard to subjective treatment success (GSR – Global
Success Rating), SP-OST participants expressed higher global
treatment success [F(1,99) = 18.53, p < 0.001] with SP-OST-
ratings being superior.
DISCUSSION
In this Phase I study we investigated whether a one session
treatment, based on an indirect exposure approach is feasible
and efficacious in a large group setting. Preliminary results
were promising: in terms of mere feasibility, our concerns
regarding patients’ doubts about effectiveness of the treatment
and a possibly consequent weak participant-inflow as well as
considerations regarding a potential mass panic or aggravation
during the session all proved ungrounded.
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FIGURE 2 | Pre- and post-treatment approach in the BAT for the LG-OST and SP-OST condition.
We observed a reduction of spider fear symptoms on
subjective and behavioral levels with large effect sizes regarding
dysfunctional beliefs, i.e., the SBQ and behavioral symptoms
(BAT) and medium effect sizes in measures focusing on
subjective fear, i.e., the FSQ and SFS. Moreover, the completer
analysis indicated the stability of LG-OST-effects within the 8-
month FU- interval. In the SPQ, however, there were only
small post-treatment effects with a point change of 1.7 or
9.6%. Similar to our LG-OST, Öst et al. (1997b) investigated
the effects of direct observation of a modeled exposure and
indirect observation of modeled exposure via a movie-clip
in two different conditions in a small group setting. They
also applied the SPQ as an outcome measure and reported a
change of 19.7% from pre- to post-treatment for the direct
observation and 24.8% for the indirect observation condition.
However, the participants of the Öst et al. (1997b) study
were spider phobic individuals reporting 30.2% higher spider
fear at baseline assessment in the direct observation condition
(Mean score = 25.4) and 16.0% higher spider fear in the
indirect observation condition (Mean score = 21.1) than LG-
OST-participants (Mean = 17.7). Although the reported post-
treatment effects were larger, SPQ-fear levels of one condition
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were higher (20.4 for direct observation) or only slightly lower
(15.1 for indirect observation) than the levels reported in LG-
OST (16.00) after treatment. Moreover, patients of the Öst
et al. (1997b) study were younger (29.50 vs. 34.65 years) and
reported higher baseline fear levels than LG-OST-participants.
Younger age and higher baseline fear both proved as factors that
foster treatment outcome in LG-OST. Furthermore, Öst et al.
(1997b) collected post-treatment data 1 week after treatment,
whereas LG-OST-participants completed the SPQ directly after
the intervention. Many items of the SPQ inquire behavioral and
subjective spider fear symptoms in specific situations, i.e., ‘If
you find a spider in the bath, would you, say, use a shower to
wash the spider down the plughole?’ Therefore, it is probable
that LG-OST-effects were not directly depicted in the post
assessment of the SPQ, because participants could not have
tested or experienced possible symptom changes by then. SPQ
being the only measure to decrease significantly from post-
treatment to FU in LG-OST underlines this point: with a total
decrease of 23.9% from pre-treatment to FU-assessment in the
LG-OST-condition, SPQ outcomes of LG-OST equaled those of
the small-group condition receiving direct modeled exposure
observation (24.0% from pre to FU) reported by Öst et al.
(1997b).
In sum, LG-OST led to reductions of subjective and BAT
symptoms in highly spider fearful individuals comparable
to effects reported of interventions using indirect exposure
strategies in smaller groups. The follow-up (FU) data suggest
that the reductions in spider fear following from treatment are
sustained in the long-term. However, in a group (Öst, 1996;
Öst et al., 1997b; Götestam, 2002) as well as in single-settings
(Hellström and Öst, 1995) strategies combining therapist-
directed direct and modeled exposure were more efficient than
indirect- or self-exposure. Accordingly, also in our SP-OST-
condition, participants reported larger pre- to post-treatment
effects than in LG-OST in half of the applied subjective fear
measures and especially in the BAT.
The study exhibits several limitations: We did not include
an untreated control group in this feasibility-trial, thereby
considering the danger of confounding post-treatment effects
with effects of repeated measurement or a regression toward
the mean in LG-OST. Furthermore, because randomization
was not used, direct comparisons between the conditions
are questionable. These facts clearly restrict the results on
comparable effectiveness. Furthermore it is remarkable, that only
29 out of 78 participants (37%) participated in the FU assessment.
As mentioned, we strived to minimize possible doubts to
participate in large group training by guarantying anonymity.
However, participants needed to actively waive anonymity to
participate in FU-measures. Nevertheless, we proved that drop-
out was unlikely to be systematic and, therefore, the reported
FU-effects can be considered as suitable indicators of long-term
effects of LG-OST.
However, our positive outcomes regarding feasibility of
indirect exposure strategies in LG-OST in highly fearful
individuals should promote research on large group exposure
treatments. As mentioned, symptom-severity resulting from
different specific phobias is highly variable and future research
should highlight the question whether large-group settings
may also be a treatment option in a sample of diagnosed
spider phobic individuals or individuals suffering from even
more restrictive phobic disorders such as dental phobia or
injection phobia. Future efforts targeting spider phobia should
eliminate the limitations of the present study, i.e., by using
living spiders and by comparing the large group effects to a
no-treatment control group condition. Hence, future research
should address the question whether the effects of the ‘gold-
standard’ intervention also sustain in a large group setting. If so,
considering the very high efficiency as well as cost-effectiveness,
LG-OST would represent a very valuable treatment tool, e.g.,
as an intermediate step within a framework of stepped care of
phobic fears. Our results suggest that a LG-OST protocol might
sufficiently address the needs for fear treatment of many but
not all of our participants. Thus, within a stepped care model,
patients might first be referred to very low intensive treatments
such as bibliotherapy or self-help books, those who still need
additional treatment might then progress to LG-OST as the
next, moderately intensive treatment option, while only LG-
OST non-responders may finally progress to individual treatment
formats.
Moreover, clinical usability and high efficiency of LG-OST
could promote research. We still do not know whether the
mechanisms identified as potentially underlying fear in lab-
based research can be translated into a more natural fear-related
context. Highly standardized treatment delivery, as warranted in
LG-OST could be a feasible component of future mechanistic fear
studies in a clinical context. The comparatively high variance in
the LG-OST outcome measures might even suit basic research.
CONCLUSION
A large group OST based on indirect, modeled exposure proved
feasible in highly fearful participants. The effectiveness of the LG-
OST-protocol equaled the effects of previously reported small
group-treatments applying comparable delivery of exposure in
individuals with spider phobia. The current ‘gold standard’
in the treatment of phobic fear consists of a combination of
direct and modeled exposure and yields larger effects than
LG-OST. However, if more direct exposure elements can be
successfully integrated into large group treatments, due to
their very high efficiency they may prove to be valuable
in treating patients with phobia, e.g., within a stepped care
approach.
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